CN104707182B - Intervertebral implant - Google Patents
Intervertebral implant Download PDFInfo
- Publication number
- CN104707182B CN104707182B CN201310696169.0A CN201310696169A CN104707182B CN 104707182 B CN104707182 B CN 104707182B CN 201310696169 A CN201310696169 A CN 201310696169A CN 104707182 B CN104707182 B CN 104707182B
- Authority
- CN
- China
- Prior art keywords
- scaffold
- intervertebral implant
- metal powder
- porous
- biomaterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007943 implant Substances 0.000 title claims abstract description 50
- 229910052751 metal Inorganic materials 0.000 claims abstract description 48
- 239000002184 metal Substances 0.000 claims abstract description 48
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 38
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 36
- 239000000843 powder Substances 0.000 claims abstract description 23
- 239000012620 biological material Substances 0.000 claims description 27
- 229920000642 polymer Polymers 0.000 claims description 20
- 238000005245 sintering Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 15
- 239000000853 adhesive Substances 0.000 claims description 9
- 230000001070 adhesive effect Effects 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 3
- 238000004804 winding Methods 0.000 claims description 3
- 229910001362 Ta alloys Inorganic materials 0.000 claims description 2
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 2
- 229910001093 Zr alloy Inorganic materials 0.000 claims description 2
- 238000007493 shaping process Methods 0.000 claims description 2
- 229910052715 tantalum Inorganic materials 0.000 claims description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- 229910052726 zirconium Inorganic materials 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 9
- 230000004927 fusion Effects 0.000 abstract description 9
- 239000000463 material Substances 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 239000011858 nanopowder Substances 0.000 description 4
- 229920002689 polyvinyl acetate Polymers 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000002639 bone cement Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 239000011118 polyvinyl acetate Substances 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 229910000861 Mg alloy Inorganic materials 0.000 description 2
- 229910001297 Zn alloy Inorganic materials 0.000 description 2
- PGTXKIZLOWULDJ-UHFFFAOYSA-N [Mg].[Zn] Chemical compound [Mg].[Zn] PGTXKIZLOWULDJ-UHFFFAOYSA-N 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 229910010293 ceramic material Inorganic materials 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010058907 Spinal deformity Diseases 0.000 description 1
- 208000020307 Spinal disease Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000007103 Spondylolisthesis Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000004791 biological behavior Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039722 scoliosis Diseases 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
Landscapes
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
一种椎间植入物,特别是指一种利用多孔氢氧基磷灰石为支架模型填入金属粉体后经烧结成形,组成局部可降解的氢氧基磷灰石/金属块材的椎间植入物,随植入人体时间氢氧基磷灰石结构逐步进行降解,并引导骨组织攀附于多孔金属内部,形成稳固上部与下部骨头融合效果。An intervertebral implant, in particular, a kind of porous hydroxyapatite as a scaffold model filled with metal powder and then sintered to form a partially degradable hydroxyapatite/metal block The intervertebral implant gradually degrades the hydroxylapatite structure as it is implanted into the human body, and guides the bone tissue to cling to the inside of the porous metal, forming a stable upper and lower bone fusion effect.
Description
技术领域technical field
本发明涉及一种医疗植入体技术领域,具体而言是指一种局部可降解且呈多孔型态的椎间植入物,藉以组成局部可降解的氢氧基磷灰石及金属混合块材,从而引导骨再生且形成稳固上、下部骨头融合的效果。The invention relates to the technical field of medical implants, in particular to a partially degradable and porous intervertebral implant, which is used to form partially degradable hydroxyl apatite and metal mixed blocks material, so as to guide bone regeneration and form the effect of stabilizing the fusion of upper and lower bones.
背景技术Background technique
按,腰椎椎间融合术,意指从两节脊椎中取出椎间盘,然后把二者融合起来。这个步骤又名为「脊柱融合术」。通常用于治疗由脊椎退化、椎间盘突出等脊柱病而引致的持续背痛、坐骨神经痛或双腿酸软无力等病患。脊柱融合也是矫正脊柱畸形(如脊柱侧弯、脊椎滑脱或脊柱创伤等)手术的其中重要环节。Press, lumbar interbody fusion, which means removing the intervertebral disc from two vertebrae and then fusing the two together. This procedure is also known as "spinal fusion". It is usually used to treat patients with persistent back pain, sciatica or weakness of legs caused by spinal diseases such as degenerative spondylosis and herniated disc. Spinal fusion is also an important part of the surgery to correct spinal deformities such as scoliosis, spondylolisthesis or spinal trauma.
如果修复骨组织的种植体(或用以修复骨组织之植入物)在提供支撑功能的同时是生物可吸收的,在实际应用上会有极大的好处。现有的脊柱融合装置是由一个金属骨架和置于其内的生物可吸收材料组成的,例如美国专利号5,645,598所示的装置。惟,该些用以修复骨组织之种植体系置于两节脊椎骨之间,却碍于该种植体本身硬度不足及相对体积小于该脊椎骨,致使该种植体产生下沉现象,反而相互磨损甚至破坏了脊椎骨与脊椎骨之间的骨组织,特别是对脊椎骨的末端平面更是带来严重伤害。It would be of great practical benefit if implants for bone repair (or implants for bone repair) were bioabsorbable while providing support. Existing spinal fusion devices consist of a metal framework with bioabsorbable material placed therein, such as the device shown in US Patent No. 5,645,598. However, these implant systems used to restore bone tissue are placed between two vertebrae, but the hardness of the implant itself is not enough and the relative volume is smaller than the vertebrae, which causes the implant to sink, and wear or even destroy each other It destroys the bone tissue between the vertebrae, especially the end plane of the vertebrae, causing serious damage.
另,目前用于组织工程学技术的支架(大部分由可生物降解的聚合物制成)具有多孔的结构可以允许细胞培养过程中活体细胞(通常取自治疗中的患者)渗入结构内。经过一段时间的细胞培养,此种有细胞的支架被植入去除免疫系统的动物(例如大鼠)或患者本人体内(为便于后续操作通常是在皮下)。在此期间(数周到数月)细胞吸收动物或患者体内提供的营养成分而迅速繁殖,同时支架本身逐渐溶解吸收。之后,就从动物或患者的皮下取出种植体(一个真正的骨组织),重新植入需要治疗的(受伤或患病)部位。例如US6,139,578;US6,200,606;US5,306,303和US6,132,463等案所描述者。In addition, scaffolds currently used in tissue engineering techniques (mostly made of biodegradable polymers) have a porous structure that allows living cells (usually taken from patients under treatment) to infiltrate the structure during cell culture. After a period of cell culture, the cellular scaffold is implanted in an immune-depleted animal (such as a rat) or in the patient himself (usually subcutaneously for subsequent manipulations). During this period (weeks to months) the cells rapidly multiply by absorbing nutrients provided by the animal or patient, while the scaffold itself gradually dissolves and absorbs. Afterwards, the implant (a real bone tissue) is removed from under the animal's or patient's skin and reimplanted in the (injured or diseased) area requiring treatment. For example, those described in US6,139,578; US6,200,606; US5,306,303 and US6,132,463.
但,如果用于组织工程技术的支架可被生物吸收、有充足的孔隙同时又可以提供支持,那么这样的材料就有很大的优越性。其中如中国专利CN 119346A:一种含有成孔剂的多孔磷酸钙骨水泥,其特征在于是由常规的磷酸钙骨水泥和成孔剂所组成,所说的成孔剂为微溶性盐、酸式盐和碱式盐或表面活性剂中的一种或一种以上。但其为无固定型态骨水泥,其机械强度差,无法单独使用作为骨融合物。However, if the scaffold used in tissue engineering technology is bioabsorbable, has sufficient porosity and can provide support at the same time, then such a material has great advantages. Wherein as Chinese patent CN 119346A: a kind of porous calcium phosphate bone cement containing pore-forming agent is characterized in that it is made up of conventional calcium phosphate bone cement and pore-forming agent, and said pore-forming agent is slightly soluble salt, acid One or more of formula salts and basic salts or surfactants. However, it is an unfixed bone cement with poor mechanical strength and cannot be used alone as a bone fusion.
又如中国专利CN 101099873A:一种多孔镁/羟基磷灰石的生产工艺方法,其特征是将羟基磷灰石粉和镁粉按比例混合,冷压成型,然后进行烧结,镁在高温下发生汽化、被蒸发,使羟基磷灰石形成多孔状。惟镁高温移除后,仅剩多孔氢氧基磷灰石本体,一样存在有机械强度差的问题。Another example is Chinese patent CN 101099873A: a production process of porous magnesium/hydroxyapatite, which is characterized in that hydroxyapatite powder and magnesium powder are mixed in proportion, cold-pressed, and then sintered, and magnesium is generated at high temperature. Vaporization and evaporation make hydroxyapatite porous. However, after the magnesium is removed at high temperature, only the porous HA remains, which also has the problem of poor mechanical strength.
另如中国专利CN 101797400A:一种含有HA奈米粉多孔可降解镁合金骨支架材料,其特征在于,所述的多孔可降解镁合金骨支架材料由加入微量细化Zn晶粒的镁粉、HA奈米粉,以及造孔剂组成,期中,镁锌合金粉微50~80%,HA奈米粉为10~20%,造孔剂组成,其中,镁锌合金粉微50~80%,HA奈米粉为10~20%,造孔剂为10~30%。惟镁高温移除后,仅剩多孔氢氧基磷灰石本体,一样存在有机械强度差的问题。Another example is Chinese patent CN 101797400A: a porous degradable magnesium alloy bone scaffold material containing HA nanopowder, characterized in that the porous degradable magnesium alloy bone scaffold material is composed of magnesium powder, HA Nano powder, and pore-forming agent, in the mid-term, magnesium-zinc alloy powder is 50-80%, HA nano-powder is 10-20%, pore-forming agent is composed, of which, magnesium-zinc alloy powder is 50-80%, HA nano-powder 10-20% for the pore-forming agent and 10-30% for the pore-forming agent. However, after the magnesium is removed at high temperature, only the porous HA remains, which also has the problem of poor mechanical strength.
再者,常规高温(通常>1000℃)烧结的孔状羟基磷灰石(HA)材料不具备足够的微米/纳米级的孔隙并且难以被生物体吸收。另一方面,常规用于骨架的可生物降解聚合物又有强度相对较低和溶解速率太高的缺点。换言之在考虑轻量化、增加生物性结合的前题下,有必要发展能促进骨引导之连通多孔金属医材。Furthermore, conventional high-temperature (usually >1000 °C) sintered porous hydroxyapatite (HA) materials do not have sufficient micro/nano-scale pores and are difficult to be absorbed by organisms. On the other hand, biodegradable polymers conventionally used for scaffolds have the disadvantages of relatively low strength and too high dissolution rate. In other words, under the premise of reducing weight and increasing biological integration, it is necessary to develop connected porous metal medical materials that can promote bone conduction.
本案发明人鉴于上述公知促进骨引导的连通多孔金属医材所衍生的各项缺点,乃亟思加以改良创新,终于成功研发完成本件一种椎间植入物。In view of the shortcomings derived from the above-mentioned interconnected porous metal medical materials that promote bone conduction, the inventor of this case desperately wanted to improve and innovate, and finally successfully developed and completed this intervertebral implant.
发明内容Contents of the invention
本发明之目的即在于提供一种椎间植入物,藉以能组成局部可降解的氢氧基磷灰石/金属块材的椎间植入物,随植入人体时间氢氧基磷灰石结构逐步进行降解,并引导骨组织攀附于多孔金属内部,形成稳固上部与下部骨头融合效果。The object of the present invention is to provide a kind of intervertebral implant, thereby can form the intervertebral implant of locally degradable hydroxyapatite/metal blocks, the hydroxyapatite The structure gradually degrades, and guides the bone tissue to cling to the inside of the porous metal, forming a stable upper and lower bone fusion effect.
本发明之次一目的在于提供一种椎间植入物,为使用陶瓷材料或金属材料的可降解高分子材料或复合物,按照仿生原理设计制造具有优异性能和结构的材料,并具有调节材料的降解速率。The second object of the present invention is to provide an intervertebral implant, which is a degradable polymer material or composite made of ceramic material or metal material, designed and manufactured according to the principle of bionics with excellent performance and structure, and has a regulating material the degradation rate.
本发明之另一目的在于提供一种具备细胞的生物学行为和培养效率的支架材料,当椎间植入物移植后能与人体腔洞具有很好的适应、结合和修复的椎间植入物。Another object of the present invention is to provide a scaffold material with the biological behavior and culture efficiency of cells, which can be well adapted, combined and repaired with the human body cavity after the intervertebral implant is implanted. thing.
本发明之又一目的在于提供一种具有良好的生物兼容性的椎间植入物,该椎间植入物在体外培养时具备无细胞毒性,植入人体内时不会引起人体骨的排斥反应的优点。Another object of the present invention is to provide an intervertebral implant with good biocompatibility, which has no cytotoxicity when cultured in vitro, and will not cause human bone rejection when implanted in the human body Advantages of the response.
本发明之再一目的在于提供一种椎间植入物,该椎间植入物具有三维立体结构,且具有高度多孔状结构,该椎间植入物具有很大的内表面积,以有利于细胞的植入、粘附,又有利于细胞营养成份的渗入和代谢产物的排出。Another object of the present invention is to provide an intervertebral implant, which has a three-dimensional structure and has a highly porous structure. The intervertebral implant has a large inner surface area to facilitate The implantation and adhesion of cells are also conducive to the infiltration of cell nutrients and the discharge of metabolites.
本发明之他一目的在于提供一种椎间植入物,该椎间植入物具有良好的表面活性,能促进细胞的粘附并为细胞在其表面的增殖提供良好的微环境。Another object of the present invention is to provide an intervertebral implant, which has good surface activity, can promote cell adhesion and provide a good microenvironment for cell proliferation on its surface.
可达成上述发明目的之一种椎间植入物,为利用多孔氢氧基磷灰石为支架模型填入金属粉体后经烧结成形,组成局部可降解之氢氧基磷灰石/金属块材的椎间植入物,其制备方法,包括如下步骤:An intervertebral implant that can achieve the purpose of the above invention is to use porous HA as the scaffold model to fill in metal powder and then sintered to form a partially degradable HA/metal block The intervertebral implant of material, its preparation method, comprises the steps:
步骤a、混合:将可于人体内产生降解作用的可降解生物材与胶黏剂液体进行搅拌,而形成一种微黏稠液体;Step a, mixing: stirring the biodegradable biomaterial that can degrade in the human body and the adhesive liquid to form a slightly viscous liquid;
步骤b、沾覆:以多孔性的高分子支架沾覆上述微黏稠液体,使得该高分子支架表面及/或其腔洞状的空间内披覆有该微黏稠液体;Step b, coating: coating the above-mentioned slightly viscous liquid with a porous polymer scaffold, so that the surface of the polymer scaffold and/or its cavity-like space is coated with the slightly viscous liquid;
步骤c、烘干定型:且在完成沾覆后进行烘干,使微黏稠液体紧密的披覆于高分子支架与腔洞状空间上,并依高分子支架与腔洞状空间原始多孔排列不同,紧密披覆于表层而呈现相同的多孔排列;Step c, drying and shaping: and drying after the coating is completed, so that the slightly viscous liquid is tightly coated on the polymer support and the cavity-like space, and the original porous arrangement of the polymer support and the cavity-like space is different , tightly coated on the surface to present the same porous arrangement;
步骤d、烧结移除:以大气炉体进行高温烧结,而将高分子支架与胶黏剂移除,以获得多孔排列的一可降解生物材支架;以及Step d, sintering removal: high-temperature sintering in an atmospheric furnace to remove the polymer scaffold and the adhesive to obtain a porous biodegradable biomaterial scaffold; and
步骤e、填充绕结:利用该可降解生物材支架为支架模型填入金属粉体,并进行真空高温烧结,以获得由可降解生物材与金属粉体相互嵌合的一椎间植入物。Step e, filling and winding: use the degradable biomaterial scaffold to fill the scaffold model with metal powder, and perform vacuum high-temperature sintering to obtain an intervertebral implant made of degradable biomaterial and metal powder. .
藉此,透过上述技术手段的具体实现,使得本发明可透过氢氧基磷灰石生物材料具有良好生物兼容性、骨传导性和生物降解性,氢氧基磷灰石/金属块材的椎间植入物内后可逐渐发生溶解和生物降解,一定时间后非生命的氢氧基磷灰石椎间植入物逐渐溶解消失,被有生命的新生骨组织所取代,亦使用氢氧基磷灰石/金属块材的椎间植入物植入人体腔洞,在氢氧基磷灰石/金属块材的椎间植入物植入人体腔洞内后逐渐引导骨组织长入腔洞状空间,同时阻止软组织的长入,从而实现氢氧基磷灰石/金属块材的椎间植入物在人体骨内牢固的机械结合,且能有效增加产品的附加价值,并提升其经济效益。Thereby, through the specific realization of the above-mentioned technical means, the permeable HA biomaterial of the present invention has good biocompatibility, osteoconductivity and biodegradability, and the HA/metal block The intervertebral implant can gradually dissolve and biodegrade after a certain period of time. After a certain period of time, the non-living hydroxyapatite intervertebral implant gradually dissolves and disappears, and is replaced by living new bone tissue. Hydrogen The intervertebral implant of oxyapatite/metal block is implanted in the human cavity, and the bone tissue is gradually guided to grow after the intervertebral implant of hydroxyapatite/metal block is implanted in the cavity of the human body. Into the cavity-like space, and at the same time prevent the growth of soft tissue, so as to realize the firm mechanical integration of the intervertebral implant of HA/metal block in human bone, and can effectively increase the added value of the product, and improve its economic efficiency.
附图说明Description of drawings
图1为本发明一种椎间植入物的简要流程示意图;Fig. 1 is a brief flow diagram of an intervertebral implant of the present invention;
图2为该一种椎间植入物的步骤制成示意图;Fig. 2 is that the step of this a kind of intervertebral implant is made schematic diagram;
图3~图6为细胞平摊于多孔金属结构表面显示皆为正常状态细胞行为之作用图。Figures 3 to 6 are diagrams showing the normal behavior of cells spread on the surface of the porous metal structure.
具体实施方式detailed description
请参阅图1,本发明所提供的一种椎间植入物,其是由金属粉体与可降解生物材共同构成;其中,该可降解生物材经烧结而具有复数连通孔,该金属粉体则填充于该复数连通孔内,并经烧结而与该可降解生物材相互嵌合。藉此,该椎间植入物所含有的可降解生物材遂可通过体液溶解和细胞介导的生物降解,一部分参与骨组织植入局部或远程的骨组织重建,另一部分逐渐被代谢系统排出体外,最终使缺损部位完全被新生的骨组织替代,而该金属支架同时起到永久支架作用,即骨组织工程支架材料。基于此,该可降解生物材亦可选择由可吸收生物材所取代,以据相同原则达成如前所述之功效。Please refer to Figure 1, an intervertebral implant provided by the present invention is composed of metal powder and degradable biomaterial; wherein, the degradable biomaterial has a plurality of communicating holes after sintering, and the metal powder The body is filled in the plurality of communicating holes, and is sintered to interfit with the degradable biomaterial. In this way, the degradable biomaterial contained in the intervertebral implant can dissolve through body fluids and cell-mediated biodegradation, part of which participates in the local or remote bone tissue reconstruction of bone tissue implantation, and the other part is gradually excreted by the metabolic system In vitro, the defect site is finally completely replaced by new bone tissue, and the metal scaffold also acts as a permanent scaffold, that is, bone tissue engineering scaffold material. Based on this, the degradable biological material can also be replaced by absorbable biological material, so as to achieve the above-mentioned effect according to the same principle.
续参图1及2,该椎间植入物由下列步骤制成,包含:步骤a、混合:将可于人体内产生降解作用的可降解生物材与胶黏剂液体进行搅拌,其搅拌温度1100~1300℃,搅拌混合时间为10~60min,而形成一种微黏稠液体;其中,该可降解生物材可以选择为氢氧基磷灰石,且该胶黏剂则可以选择为聚乙酸乙烯酯(也称作聚醋酸乙烯酯,简称PVA、PVAc),其属于一种有弹性的合成聚合物,较佳者,本实施例系由氢氧基磷灰石混和聚乙酸乙烯酯,以形成如图2所示之氢氧基磷灰石/PVA浆料;Continuing to refer to Figures 1 and 2, the intervertebral implant is made by the following steps, including: step a, mixing: stirring the degradable biomaterial that can degrade in the human body and the adhesive liquid, the stirring temperature 1100~1300℃, stirring and mixing time is 10~60min to form a slightly viscous liquid; among them, the degradable biomaterial can be selected as hydroxyapatite, and the adhesive can be selected as polyvinyl acetate Ester (also known as polyvinyl acetate, referred to as PVA, PVAc), which belongs to a kind of elastic synthetic polymer, preferably, this embodiment is mixed with polyvinyl acetate by hydroxyl apatite to form Hydroxyapatite/PVA slurry as shown in Figure 2;
步骤b、沾覆:以多孔性之高分子支架(high-molecular support)与上述微黏稠液体进行沾覆作业而于高分子支架表面及/或腔洞状的空间内披覆有该微黏稠液体;其中该高分子支架为陶瓷材料或金属材料所制成,其皆如图2所示的高分子支架具有复数腔洞状空间;Step b. Coating: The porous polymer support (high-molecular support) is coated with the above-mentioned slightly viscous liquid, and the surface of the polymer support and/or the cavity-like space is coated with the slightly viscous liquid ; Wherein the polymer scaffold is made of ceramic material or metal material, and the polymer scaffold as shown in Figure 2 has a plurality of cavity-like spaces;
步骤c、烘干定型:且在完成沾覆后于烘箱进行烘干,烘干温度50~100℃,烘干定型时间为8~24hr,使微黏稠液体紧密的披覆于高分子支架表面及/或腔洞状空间上,并依高分子支架及/或腔洞状空间原始多孔排列不同,紧密披覆于表层而呈现相同多孔排列;较佳者,本实施例以该高分子支架沾附氢氧基磷灰石/PVA浆料后,系使得该高分子支架表面及其腔洞状空间内均披覆有前述之浆料,且呈多孔型态排列;Step c. Drying and setting: After finishing the coating, dry in an oven at a temperature of 50-100°C and a drying and setting time of 8-24 hours, so that the slightly viscous liquid can be tightly coated on the surface of the polymer support and /or cavity-like space, and depending on the original porous arrangement of the polymer scaffold and/or cavity-like space, it is tightly covered on the surface to present the same porous arrangement; preferably, this embodiment uses the polymer scaffold to adhere After the hydroxylapatite/PVA slurry, the surface of the polymer scaffold and the cavity-like space are coated with the aforementioned slurry, and arranged in a porous form;
步骤d、烧结移除:以大气炉体进行高温烧结,高温烧结温度1100~1300℃,而将高分子支架与胶黏剂移除,进而获得多孔排列的可降解生物材支架,详参图2;以及Step d, sintering removal: Carry out high-temperature sintering in an atmospheric furnace, the high-temperature sintering temperature is 1100-1300°C, and remove the polymer scaffold and adhesive, and then obtain a porous biodegradable biomaterial scaffold, see Figure 2 for details ;as well as
步骤e、填充绕结:利用多孔可降解生物材支架为支架模型(supportmountingmodel)填入金属粉体,其中该可降解生物材支架的支架模型可呈连通孔立体结构,且该可降解生物材支架的支架模型的线径结构宽度为10μm~200μm,而金属粉体可选自能以烧结成形方式制备之钛、钛合金、锆、锆合金、钽、钽合金之其一或其一以上混合,且金属粉体烧结后其呈现均一金属球体结构大小,并等同于未烧结前金属粉体粒径,又金属粉体粒径介于10μm~100μm之间;待金属粉体填入该高分子支架后,随之进行真空高温烧结,真空高温烧结温度较家系控制于1100~1300℃,烘干定型时间为1~3h,以获得该可降解生物材与金属粉体相互嵌合的该椎间植入物;较佳者,本实施例系获得可如图2之氢氧基磷灰石与金属共同烧结而成的块材结构(即图面之一种局部可降解引导股再生之多孔金属结构),该块材即为本发明之呈多孔型态的椎间植入物。Step e, filling and winding: using a porous degradable biomaterial support to fill the support mounting model with metal powder, wherein the support mounting model of the degradable biomaterial support can have a three-dimensional structure of interconnected holes, and the degradable biomaterial support The wire diameter structure width of the stent model is 10 μm to 200 μm, and the metal powder can be selected from titanium, titanium alloy, zirconium, zirconium alloy, tantalum, tantalum alloy or a mixture of more than one that can be prepared by sintering. And after the metal powder is sintered, it presents a uniform metal sphere structure size, which is equal to the particle size of the metal powder before sintering, and the particle size of the metal powder is between 10 μm and 100 μm; when the metal powder is filled into the polymer support Afterwards, vacuum high-temperature sintering is carried out, and the vacuum high-temperature sintering temperature is controlled at 1100-1300 °C compared with the family, and the drying and setting time is 1-3 hours, so as to obtain the intervertebral implant in which the degradable biomaterial and metal powder are embedded with each other. Injection; Preferably, the present embodiment is to obtain a block structure that can be sintered together with metal as shown in Figure 2 (a porous metal structure that is partially degradable and guides the regeneration of the drawing ), the block is the porous intervertebral implant of the present invention.
藉此,透过上述的制备方法可获得氢氧基磷灰石/金属块材的椎间植入物植入人体腔洞来保证椎间植入物植入后骨组织能逐渐长入腔洞状空间,其中氢氧基磷灰石植入于人体中为可降解之材质,氢氧基磷灰石材料中的物质结构是决定其生物降解性的关键因素,氢氧基磷灰石的钙磷比率(Ca/P)为1.65~1.75,烧结后仍保持磷灰石(apatite)物质结构,在新骨形成过程中产生骨引导作用,藉由植入时间之增加而缓慢进行降解,其慢速降解过程中,能利用氢氧基磷灰石优秀的骨引导功效,引导新骨组织从宿主骨沿氢氧基磷灰石/金属块材之椎间植入物进入氢氧基磷灰石/金属块材的椎间植入物内部,达到上部与下部骨组织稳固愈合与实现牢固的机械固定之功效。In this way, through the above preparation method, the intervertebral implant of HA/metal block can be implanted into the cavity of the human body to ensure that the bone tissue can gradually grow into the cavity after the intervertebral implant is implanted. shape space, in which HA is a degradable material implanted in the human body. The material structure of HA material is the key factor to determine its biodegradability. Calcium of HA Phosphorus ratio (Ca/P) is 1.65-1.75. After sintering, it still maintains the structure of apatite (apatite), which produces bone conduction in the process of new bone formation, and slowly degrades with the increase of implantation time. During the rapid degradation process, the excellent bone conduction effect of HA can be used to guide new bone tissue from the host bone along the HA/metal block intervertebral implant into HA /Inside the intervertebral implant of the metal block, it achieves the effect of stable healing of the upper and lower bone tissues and a firm mechanical fixation.
综上所述,透过前述的结构设计,本发明能制备出一种多孔金属结构,藉以能组成局部可降解之氢氧基磷灰石/金属块材的椎间植入物,随其植入人体的时间,使其中氢氧基磷灰石结构逐步进行降解,并在降解过程中,引导骨组织攀附于多孔金属结构内部,使植入部形成稳固的上部与下部之骨头融合效果,令其进一步具有轻易化及增加生物性结合的功效。In summary, through the aforementioned structural design, the present invention can prepare a porous metal structure, so as to form an intervertebral implant of locally degradable HA/metal block, and then implant it During the time of entering the human body, the hydroxyl apatite structure gradually degrades, and during the degradation process, the bone tissue is guided to cling to the inside of the porous metal structure, so that the implanted part forms a stable upper and lower bone fusion effect, so that It further has the effect of facilitating and increasing biological conjugation.
本发明所提供的一种椎间植入物,与前述引证案及其它习用技术相互比较时,更具有下列优点:A kind of intervertebral implant provided by the present invention has the following advantages when compared with the aforementioned cited cases and other conventional technologies:
该氢氧基磷灰石/金属块材的椎间植入物具有生物可降解性,椎间植入物在骨组织形成过程中应逐渐被降解,并且不影响新生成骨组织的结构和功能。The intervertebral implant of hydroxyapatite/metal block is biodegradable, and the intervertebral implant should be gradually degraded during the formation of bone tissue without affecting the structure and function of newly formed bone tissue .
该氢氧基磷灰石/金属块材的椎间植入物具有可塑性,可被加工成所需要的形状并具有一定的机械强度,在椎间植入物内后的一定时间内仍可保持其形状,并使新形成的组织具有符合设计的外形。The intervertebral implant of the hydroxyapatite/metal block has plasticity, can be processed into a desired shape and has a certain mechanical strength, and can still be maintained for a certain period of time after the intervertebral implant its shape and give the newly formed tissue the shape it was designed for.
上列详细说明系针对本发明之一可行实施例之具体说明,惟该实施例并非用以限制本发明之专利范围,凡未脱离本发明技艺精神所为之等效实施或变更,均应包含于本案之专利范围中。The above detailed description is a specific description of a feasible embodiment of the present invention, but this embodiment is not used to limit the patent scope of the present invention, and any equivalent implementation or change that does not depart from the technical spirit of the present invention shall include within the patent scope of this case.
综上所述,本案不但在空间型态上确属创新,并能较习用物品增进上述多项功效,应已充分符合新颖性及进步性之法定发明专利要件,爰依法提出申请,恳请贵局核准本件发明专利申请案,以励发明,至感德便。To sum up, this case is not only innovative in terms of space type, but also can enhance the above-mentioned multiple functions compared with commonly used items. It should have fully met the statutory requirements for a novelty and progressive invention patent. I would like to file an application in accordance with the law. I sincerely request your office Approval of this invention patent application to encourage inventions is very grateful.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310696169.0A CN104707182B (en) | 2013-12-16 | 2013-12-16 | Intervertebral implant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310696169.0A CN104707182B (en) | 2013-12-16 | 2013-12-16 | Intervertebral implant |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104707182A CN104707182A (en) | 2015-06-17 |
CN104707182B true CN104707182B (en) | 2017-08-11 |
Family
ID=53407221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310696169.0A Active CN104707182B (en) | 2013-12-16 | 2013-12-16 | Intervertebral implant |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104707182B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107402373A (en) * | 2016-05-19 | 2017-11-28 | 财团法人金属工业研究发展中心 | Area type positioning module |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100389733C (en) * | 2004-11-29 | 2008-05-28 | 西安理工大学 | Preparation method of spherical inner hole artificial bone with gradient pore structure |
WO2008122595A2 (en) * | 2007-04-05 | 2008-10-16 | Cinvention Ag | Biodegradable therapeutic implant for bone or cartilage repair |
KR101289122B1 (en) * | 2008-03-18 | 2013-07-23 | 한국보건산업진흥원 | COMPLEX IMPLANTS INFILTERATED WITH BIODEGRADABLE Mg(ALLOYS) INSIDE POROUS STRUCTURAL MATERIALS AND METHOD FOR MANUFACTURING THE SAME |
US8383187B2 (en) * | 2009-02-19 | 2013-02-26 | Depuy Products, Inc. | Rough porous constructs |
CN103357063B (en) * | 2012-04-10 | 2016-07-06 | 中国科学院金属研究所 | The metallic composite of a kind of bootable osteogenesis and application thereof |
-
2013
- 2013-12-16 CN CN201310696169.0A patent/CN104707182B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104707182A (en) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pei et al. | 3D printed titanium scaffolds with homogeneous diamond-like structures mimicking that of the osteocyte microenvironment and its bone regeneration study | |
ES2431672T3 (en) | Metal oxide scaffolding | |
CN204581484U (en) | A kind of 3D with three-dimensional through loose structure prints bone screw | |
Kumar et al. | Biocompatibility and mechanical behaviour of three-dimensional scaffolds for biomedical devices: process–structure–property paradigm | |
TWI394597B (en) | Biodegradable scaffold bone graft for orthopaedic use | |
CN102512267A (en) | Bone restoration body with composite porous structure and preparation method thereof | |
CN102440852A (en) | A hybrid porous structure intervertebral fusion device and its preparation method | |
Abdurrahim et al. | Recent progress on the development of porous bioactive calcium phosphate for biomedical applications | |
WO2012174837A1 (en) | Bionic bone repairing scaffold of layered structure and manufacturing method thereof | |
CN111939319B (en) | Bioactive porous polyether-ether-ketone and preparation method and application thereof | |
WO2021120353A1 (en) | Metal prosthesis of composite porous biological ceramic, and preparation method therefor | |
CN105506586A (en) | Method for preparing degradable magnesium cage implant with antibacterial and anti-corrosion graphene/apatite composite coating | |
Pang et al. | In vitro and in vivo evaluation of biomimetic hydroxyapatite/whitlockite inorganic scaffolds for bone tissue regeneration | |
CN112603603A (en) | Personalized prosthesis with antibacterial and bone promoting effects and its preparation method | |
US9498337B2 (en) | Intervertebral implant | |
WO2011130812A2 (en) | Suspensions for preparing biosilicate-based bone grafts (scaffolds), thus obtained bone grafts and methods for producing same | |
Mekala et al. | Review on engineering biomaterials in tissue engineering application | |
Dorozhkin | Calcium-orthophosphate-based bioactive ceramics | |
CN104707182B (en) | Intervertebral implant | |
TWI615136B (en) | Intervertebral implant and preparation method thereof | |
CN109432493A (en) | Porous titanium framework of nano hydroxyapatite coating and its preparation method and application | |
KR102148814B1 (en) | Bone graft of biodegradable metal and method for preparing therefor | |
CN203609545U (en) | Condyle process prosthesis | |
Dellinger | Development of model hydroxyapatite bone scaffolds with multiscale porosity for potential load bearing applications | |
Adhikari et al. | Synthesis and characterization of Chitosan-Mg-Based composite scaffolds for bone repair applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |